Find trials
Search tips

Active Clearance Technology (ACT) Registry

Overview

About this study

The purpose of this study is to evaluate the effectiveness of the PleuraFlow® Active Clearance Technology™ (ACT) System in the management of blood evacuation after cardiac surgery.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  1. Male or Female subjects 18 years of age or older who received a PleuraFlow System following heart surgery.
  2. Patient undergoing cardiac surgery via sternotomy

Exclusion Criteria:

  1. Robotic surgery
  2. Any access via thoracotomy
  3. Any condition deemed inappropriate for inclusion by the investigators.
  4. Intolerance to implantable silicone materials

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status

Rochester, Minn.

Mayo Clinic principal investigator

John Stulak, M.D.

Closed for enrollment

More information

Publications

Publications are currently not available

More about research at Mayo Clinic

.
CLS-20271276

Mayo Clinic Footer